Latest Breaking News On - Allarity therapeutics inc - Page 4 : comparemela.com

Allarity Therapeutics Announces 1-for-20 Reverse Stock

Boston (April 4, 2024) Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to.

Thomas pedersenAllarity therapeutics incCompany contactCompany certificate of incorporationCompany board of directorsCarrotize pr communicationsExchange commissionAllarity therapeuticsReverse stock splitSpecial meetingStock splitReverse stockComputershare limitedDrug response predictorCompanion diagnosticPrivate securities litigation reform act

Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer

Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Allarity therapeutics incAllarity therapeutics

Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward

Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward
smdailyjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from smdailyjournal.com Daily Mail and Mail on Sunday newspapers.

Thomas pedersenThomas jensenJeremyr graffAllarity thomas jensenMerck kgaaAllarity therapeutics incMerck kgaCarrotize pr communicationsCompany contactEisai coJiangsu hengrui pharmaceuticalsExchange commissionAllarity therapeuticsExecutive advisor jeremyAntibody drug conjugateComplete responder

Allarity Therapeutics (ALLR) to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval

Allarity Therapeutics (ALLR) to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Thomas jensenJeremyr graffAllarity thomas jensenJiangsu hengrui pharmaceuticalsMerck kgaAllarity therapeutics incMerck kgaaAllarity therapeuticsExecutive advisor jeremyAntibody drug conjugateComplete responder

Allarity Therapeutics Receives Extension from Nasdaq Hearings Panel to Regain Compliance with

Boston (March 25, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that the Company has

Thomas pedersenThomas jensenAllarity therapeutics incCarrotize pr communicationsCompany contactExchange commissionNasdaq hearings panel onAllarity therapeuticsNasdaq listing rulesListing ruleNasdaq hearings panelBid price ruleNasdaq capital marketCommon stockDrug response predictorPrivate securities litigation reform act